Forefront Analytics’s Surface Oncology SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-61,156
Closed -$42.7K – 79
2023
Q1
$42.7K Sell
61,156
-2,200
-3% -$1.78K 0.02% 76
2022
Q4
$52K Sell
63,356
-3,482
-5% -$3.43K 0.03% 69
2022
Q3
$70K Buy
66,838
+25,150
+60% +$40.2K 0.04% 58
2022
Q2
$71K Buy
41,688
+21,975
+111% +$45.6K 0.03% 56
2022
Q1
$62K Buy
+19,713
New +$69.1K 0.02% 67

Other funds holding SURF

Forefront Analytics's SURF Position: Q2 2023 in Review

Forefront Analytics sold out of Surface Oncology (SURF) in Q2 2023, closing a stake of 61,156 shares — an estimated $42.7K sold.

Forefront Analytics first reported a position in SURF in Q1 2022 and held it in 5 quarters. The position peaked at $71K in Q2 2022. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

  • Forefront Analytics reported no remaining Surface Oncology position as of Q2 2023 after selling out during the quarter.
  • Forefront Analytics sold 61,156 Surface Oncology shares in Q2 2023, an estimated $42.7K.
  • Forefront Analytics first reported a position in Surface Oncology in Q1 2022 and held it in 5 quarters.
  • Forefront Analytics's Surface Oncology position peaked at $71K in Q2 2022.
  • 61 funds tracked by Wall St. Rank held Surface Oncology as of Q2 2023.

Based on Forefront Analytics's 13F filing for Q2 2023, filed 11 Aug 2023.